Skip to content
Ask Dr. Calapai
The Stem Cell Foundation
  • Home
  • About Us
  • Videos
  • Articles
  • Donate
  • Contact Us
  • Toggle website search
Menu Close
  • Home
  • About Us
  • Videos
  • Articles
  • Donate
  • Contact Us
  • Toggle website search

Blog

  1. Home>
  2. 2008>
  3. October>
  4. 20>
  5. Articles>
  6. Immune disrupting effect of arsenic; Inorganic arsenite induces HLA-DR strong positive dendritic macrophage generation from human peripheral blood monocytes

Immune disrupting effect of arsenic; Inorganic arsenite induces HLA-DR strong positive dendritic macrophage generation from human peripheral blood monocytes

  • Post author:2by2host
  • Post published:October 20, 2008
  • Post category:Articles

.

Please Share This Share this content

  • Opens in a new window X
  • Opens in a new window Facebook
  • Opens in a new window Pinterest
  • Opens in a new window LinkedIn
  • Opens in a new window Viber
  • Opens in a new window VK
  • Opens in a new window Reddit
  • Opens in a new window Tumblr
  • Opens in a new window Viadeo
  • Opens in a new window WhatsApp

You Might Also Like

Bone Marrow Stem Cell Treatment for Ischemic Heart Disease in Patients with No Option of Revascularization: A Systematic Review and Meta-Analysis

February 27, 2017

Serum Zinc Level and Coronary Heart Disease Events in Patients With Type 2 Diabetes

August 24, 2009

Fermented Wheat Germ Extract (Avemar) in the Treatment of Cancer and Autoimmune Diseases

May 24, 2013

Categories

  • Articles
  • Stem Cells
  • Videos

Recent Posts

  • Autologous hematopoietic stem cell transplantation in neuromyelitis optica: A registry study of the EBMT Autoimmune Diseases Working Party
  • Update on mesenchymal stem cell-based therapy in lupus and scleroderma
  • Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications
  • Mesenchymal Stem Cells Are Recruited into Wounded Skin and Contribute to Wound Repair by Transdifferentiation into Multiple Skin Cell Type
  • The safety of bone-marrow derived mesenchymal stem cells in patients with type 2 diabetes mellitus

Follow Us

Copyright 2025